Shares of Orthopediatrics Corp (NASDAQ:KIDS) have been assigned an average rating of “Buy” from the seven analysts that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $39.33.
KIDS has been the topic of a number of analyst reports. BTIG Research boosted their price objective on Orthopediatrics to $44.00 and gave the company a “buy” rating in a research note on Friday, March 8th. BidaskClub upgraded Orthopediatrics from a “hold” rating to a “buy” rating in a research report on Thursday, December 20th. Zacks Investment Research upgraded Orthopediatrics from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a research report on Wednesday, January 2nd. Finally, JMP Securities began coverage on Orthopediatrics in a research report on Wednesday, February 20th. They set an “outperform” rating and a $44.00 target price for the company.
A number of institutional investors have recently bought and sold shares of KIDS. Northern Trust Corp grew its position in Orthopediatrics by 64.0% during the second quarter. Northern Trust Corp now owns 88,863 shares of the company’s stock worth $2,367,000 after buying an additional 34,687 shares in the last quarter. Regal Investment Advisors LLC purchased a new position in shares of Orthopediatrics in the 3rd quarter worth about $246,000. JPMorgan Chase & Co. boosted its holdings in shares of Orthopediatrics by 20.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 70,225 shares of the company’s stock worth $2,573,000 after purchasing an additional 11,931 shares in the last quarter. Rhumbline Advisers purchased a new position in shares of Orthopediatrics in the 3rd quarter worth about $207,000. Finally, EAM Investors LLC boosted its holdings in shares of Orthopediatrics by 118.8% in the 3rd quarter. EAM Investors LLC now owns 68,217 shares of the company’s stock worth $2,499,000 after purchasing an additional 37,045 shares in the last quarter. Institutional investors and hedge funds own 51.70% of the company’s stock.
Orthopediatrics (NASDAQ:KIDS) last issued its earnings results on Wednesday, March 6th. The company reported ($0.19) earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.19). Orthopediatrics had a negative return on equity of 22.99% and a negative net margin of 20.89%. The firm had revenue of $14.60 million for the quarter, compared to analyst estimates of $14.50 million. During the same period in the previous year, the company posted ($1.41) earnings per share. The business’s revenue was up 24.8% on a year-over-year basis. Sell-side analysts anticipate that Orthopediatrics will post -0.41 earnings per share for the current fiscal year.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Further Reading: Cash Flow
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.